Issue 80 of our journal Cuadernos now available
Issue 80 of the journal Cuadernos, with highly topical content for the pharmaceutical sector, is available for purchase and download.
Categoría: News
CEFI, 40 years working in defence of innovation and intellectual property
We at the CEFI Foundation are very proud to celebrate our 40th Anniversary this year. CEFI has been working in defence of innovation and intellectual property for 40 years, especially in the biomedical field. Thanks to the collaboration of leading experts, authorities and thousands of supporters, we are celebrating four decades of debate and analysis […]
Issues 79 and 94 of our journals now available
Issue 79 of the journal Cuadernos, with highly topical content for the pharmaceutical sector, is available for purchase and download. Don’t miss out on issue 94 of the Comunicaciones journal!!
ADVERTISING MEDICINAL PRODUCTS IN THE INTERIM PERIOD BETWEEN MARKETING AUTHORISATION AND THE DECISION ON PRICING AND PUBLIC FUNDING
This paper analyses the promotion of medicines for human use that have already received marketing authorization, when the advertising is made before the resolution on pricing and inclusion in the Spanish National Health Service. This is an issue addressed by the recent Judgment of the High Court of Justice of the Basque Country (Administrative Chamber) […]
STRONG INTEREST IN OUR DISCUSSION ON OBSERVATIONAL STUDIES ON MEDICATIONS AND PATIENT SUPPORT PROGRAMMES
On 15 October we had an interesting discussion on Observational Studies on Medications and patient support programmes in the new regulations that aroused a lot of interest. More than 90 people participated in the session with strong participation in questions and comments. With his extensive knowledge of the subject, Lluis Alcover informed us of the […]
PHARMACEUTICAL LAW PUBLICATION nº 78 Available for purchase and download
The promotion of medicines for human use that have already receive marketing authorization, before the resolution on pricing and the inclusión in the Nacional Health System. Angel García Vidal and Irene Fernández Puyol Health Data 29 Playbook as a gvernance framework fot he sharing and researchwith healthcaredata. Ricard Martínez Martínez, Gabriel López Serrano, Alejandro Padín […]
Advertising of medicinal products before a financing decision by the National Health System
Superior Court of Justice of the Basque Country, Judicial Review Chamber, Judgment 246/2021 of 30 June resolved positively on a question widely debated in the sector: the possibility of advertising medicinal products that have been approved for sale but have yet to receive a decision on their financing. This judgment is in line with the […]
Observational studies of medicinal products and patient support programmes in the new regulation
CEFI is organising a seminar on observational studies of medicinal products and patient support programmes, which is set to take place on 15 October. As of 2 January 2021, observational studies of medicinal products for human use (‘OSM’) are to be regulated in Spain by Royal Decree 957/2020, which repeals the previously applicable Order SAS/3470/2009. […]
nº93 COMMUNICATIONS ON INDUSTRIAL PROPERTY AND COMPETITION LAW
Available for download. The promotion of medicines for human use that have already receive marketing authorization, before the resolution on pricing and the inclusión in the Nacional Health System. Angel García Vidal and Irene Fernández Puyol Health Data 29 Playbook as a gvernance framework fot he sharing and researchwith healthcaredata. Ricard Martínez Martínez, Gabriel López […]
The National Court of Spain (Audiencia Nacional) paves the way for a final confirmation of the legality of free price policies
In a recent ruling dated 22 April 2021, the National Court has upheld the Spanish National Markets and Competition Commission (CNMC) decision of 19 January 2017, which declared that the pricing system established by the defendant company did not amount to an anti-competitive dual pricing agreement. Following a lengthy saga played out in administrative and […]
PHARMACEUTICAL LAW PUBLICATION nº 77
Considerations on the pricing system for medicinal products. Lourdes Fraguas Gadea Abuse of dominant position consisting on predatory prices. Spanish Competition Authority Astrazeneca inhalers Decision. Alfonso Gutiérrez Hernández and Alberto Pérez Hernández Public supply of medicines. Doctrine generated by the Spanish Review Commissions on Public Procurement as of the entry into force of the Spanish […]
Council conclusions on intellectual property policy
It takes as its starting point, inter alia, the current situation as regards identifying intellectual property as a key asset for the EU, as a driver of innovation, competitiveness, economic growth and sustainable development. It highlights the contribution of intellectual property in tackling the COVID-19 pandemic and the need for urgent measures to support R&D. […]